A new risk-based screening criterion for treatment-demanding retinopathy of prematurity in Denmark

Carina Slidsborg1, Julie Lyng Forman, Steen Rasmussen

  • 1Department of Ophthalmology, Glostrup Hospital, Nordre Ringvej 57, 2600 Glostrup, Denmark. carinaslidsborg@hotmail.com

Pediatrics
|February 16, 2011
PubMed

Insights

A new risk-based criterion for retinopathy of prematurity screening in Denmark is highly effective. Implementing a 0.13% risk threshold safely identifies all infants needing treatment while reducing the number screened.

Area of Science:

  • Neonatology
  • Ophthalmology
  • Public Health

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
  • Current screening protocols in Denmark may not be optimally effective or safe.
  • Identifying the best screening criteria is crucial for early intervention and preventing blindness.

Purpose of the Study:

  • To determine the most effective and safe screening criterion for retinopathy of prematurity in Denmark.
  • To evaluate risk-based screening criteria against traditional methods.

Main Methods:

  • Retrospective national cohort study using data from 3 national registers.
  • Analysis of infants treated for ROP, those missed by screening, and candidates for ROP development.
  • Nonlinear logistic regression model to evaluate various screening criteria.

Main Results:

  • Risk-based criteria were more effective than gestational age and birth weight limits.
  • A 0.13% risk-based criterion detected all treated infants and reduced the screened population by 17.4%.
  • This criterion is predicted to miss 1 case of treatment-demanding ROP every 11 years and cause 1 case of blindness every 18 years.

Conclusions:

  • Risk-based screening criteria are superior for ROP detection.
  • A 0.13% risk threshold is a safe and effective criterion for ROP screening in Denmark.
Abstract